Novel Dose Adjustment Schedule for Late Injection in SCIT in AR

NCT04929093 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Allergic Rhinitis
Immunotherapy

Interventions

BIOLOGICAL: Novel dose adjustment of Alutard SQ
BIOLOGICAL: conventional dose adjustment of Alutard SQ
BIOLOGICAL: Routine continuous cluster of Alutard SQ

Sponsor

Beijing Tongren Hospital